The world’s largest vaccine producer, the Serum Institute, announced a plan to make hundreds of millions of doses of an unproven inoculation. It’s a gamble with a huge upside. And huge risks.
By the time the trials finish, expected around November, Serum plans to have stockpiled 300 million doses of the Oxford vaccine for commercial use.
And if all of those fail, they can quickly adapt their assembly lines to manufacture whatever vaccine candidate does work ..
Read the full news - https://www.nytimes.com/2020/08/01/world/asia/coronavirus-vaccine-india.html